Use of photosensitising diuretics and risk of skin cancer: A population-based case-control study

British Journal of Cancer

Volumn 99, Issue 9, 2008, Pages 1522-1528

  Jensen, A O ^a   Thomsen, H F ^a   Engebjerg, M C ^a   Olesen, A B ^a   Sorensen H T ^a   Karagas, M R ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Diuretics; Epidemiology; Photosensitising reaction; Risk; Skin cancer

Indexed keywords

AMILORIDE; BENDROFLUMETHIAZIDE; BUMETANIDE; DIURETIC AGENT; FUROSEMIDE; GLUCOCORTICOID; HYDROCHLOROTHIAZIDE; INDAPAMIDE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; HEAD AND NECK TUMOR; HUMAN; MELANOMA; POPULATION RESEARCH; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DERMATITIS, PHOTOTOXIC; DIURETICS; HUMANS; MELANOMA; MIDDLE AGED; RISK FACTORS; SKIN NEOPLASMS;

EID: 55249091811     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604686     Document Type: Article

References (33)

1. Addo HA, Ferguson J, Frain-Bell W (1987) Thiazide-induced photosensitivity: a study of 33 subjects. Br J Dermatol 116: 749-760
2. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46: 263-268
3. Davis R, Wells CH, Taylor AR (1979) Photolytic decomposition of indapamide. J Pharm Sci 68: 1063-1064
4. Diffey BL, Langtry J (1989) Phototoxic potential of thiazide diuretics in normal subjects. Arch Dermatol 125: 1355-1358
5. Fox MP, Lash TL, Greenland S (2005a) A method to automate probabilistic sensitivity analyses of misclassified binary variables. Int J Epidemiol 34: 1370-1376
6. Fox MP, Lash TL, Greenland S (2005b) Boston University Sensitivity Analysis Tools. Available at: http://sph.bu.edu/index.php?option=com_ content&task=view&id=405&Itemid=508#epidemiologic
7. Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287: 2398-2399
8. Frentz G (1996) General skin cancer. Quantity, treatment and quality. Ugeskr Laeger 158: 7202
9. Frentz G, Olsen JH (1999) Malignant tumours and psoriasis: a follow-up study. Br J Dermatol 140: 237-242
10. Frishman WH, Brosnan BD, Grossman M, Dasgupta D, Sun DK (2002) Adverse dermatologic effects of cardiovascular drug therapy: part II. Cardiol Rev 10: 285-300
11. Gallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, McLean DI, Threlfall WJ (1995) Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 131: 157-163
12. Greenland S (2005) Multiple-bias modeling for analysis of observational data (with discussion). J Roy Stat Soc 168: 267-306
13. Jensen AO, Olesen AB, Dethlefsen C, Sorensen HT (2007) Do incident and new subsequent cases of non-melanoma skin cancer registered in a Danish prospective cohort study have different 10-year mortality? Cancer Detect Prev 31: 352-358
14. Jensen AO, Olesen AB, Dethlefsen C, Sorensen HT, Karagas MR (2008) Chronic diseases requiring hospitalization and risk of non-melanoma skin cancers-a population based study from Denmark. J Invest Dermatol 128: 926-931
15. Johnston GA (2002) Thiazide-induced lichenoid photosensitivity. Clin Exp Dermatol 27: 670-672
16. Karagas MR, Cushing Jr GL, Greenberg ER, Mott LA, Spencer SK, Nierenberg DW (2001) Non-melanoma skin cancers and glucocorticoid therapy. Br J Cancer 85: 683-686
17. Karagas MR, Stukel TA, Umland V, Tsoukas MM, Mott LA, Sorensen HT, Jensen AO, Nelson HH, Spencer SK, Perry AE, Stern RS (2007) Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: results of a population-based case-control study. J Invest Dermatol 127: 2901-2903
18. Larue L, Dougherty N, Mintz B (1992) Genetic predisposition of transgenic mouse melanocytes to melanoma results in malignant melanoma after exposure to a low ultraviolet B intensity nontumorigenic for normal melanocytes. Proc Natl Acad Sci USA 89: 9534-9538
19. Lindelof B, Sigurgeirsson B, Tegner E, Larko O, Johannesson A, Berne B, Christensen OB, Andersson T, Torngren M, Molin L, Nylander-Lundquist E, Emtestam L (1991) PUVA and cancer: a large-scale epidemiological study. Lancet 338: 91-93
20. Moore DE (2002) Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf 25: 345-372
21. Nielsen GL, Sorensen HT, Weijin Z, Steffensen FH, Olsen J (1997) The Pharmacoepidemiologic Prescription database of North jutland - a valid tool in pharmacoepidemiological research. Int J Risk Safety Med 10: 203-205
22. Robinson HN, Morison WL, Hood AF (1985) Thiazide diuretic therapy and chronic photosensitivity. Arch Dermatol 121: 522-524
23. Rothman KJ (2002) 'Epidemiology: an introduction,'. Oxford University Press: New York
24. Schwarze HP, Albes B, Marguery MC, Loche F, Bazex J (1998) Evaluation of drug-induced photosensitivity by UVB photopatch testing. Contact Derm 39: 200
25. Sorensen HT, Mellemkjaer L, Nielsen GL, Baron JA, Olsen JH, Karagas MR (2004) Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study. J Natl Cancer Inst 96: 709-711
26. Stern RS (1998) Photocarcinogenicity of drugs. Toxicol Lett 102-103: 389-392
27. Stern RS (2001) The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 44: 755-761
28. Stern RS, Laird N (1994) The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study. Cancer 73: 2759-2764
29. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL (1984) Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 310: 1156-1161
30. Stern RS, Liebman EJ, Vakeva L (1998) Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. J Natl Cancer Inst 90: 1278-1284
31. Storm HH, Michelsen EV, Clemmensen IH, Pihl J (1997) The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 44: 535-539
32. Thestrup-Pedersen K (1987) Adverse reactions in the skin from antihypertensive drugs. Dan Med Bull 34(Suppl 1): 3-5
33. Wacholder S, McLaughlin JK, Silverman DT, Mandel JS (1992) Selection of controls in case - control studies. I. Principles. Am J Epidemiol 135: 1019-1028